The Enterprise Value as of December 2025 (TTM) for Arecor Therapeutics plc (AREC.L) is 29.04M

According to Arecor Therapeutics plc’s latest financial reports and current stock price. The company's current Enterprise Value is 29.04M. This represents a change of -7.16% compared to the average of 31.28M of the last 4 quarters.

Arecor Therapeutics plc (AREC.L) Historical Enterprise Value (quarterly & annually)

How has AREC.L Enterprise Value performed in the past?

The mean historical Enterprise Value of Arecor Therapeutics plc over the last ten years is 52.45M. The current 29.04M Enterprise Value has changed 5.44% with respect to the historical average. Over the past ten years (40 quarters), AREC.L's Enterprise Value was at its highest in in the December 2021 quarter at 93.26M. The Enterprise Value was at its lowest in in the May 2017 quarter at -452195.00.

Arecor Therapeutics plc (AREC.L) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Arecor Therapeutics plc Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Arecor Therapeutics plc (AREC.L) Average Enterprise Value

How has AREC.L Enterprise Value performed in the past?

The current Enterprise Value of Arecor Therapeutics plc (AREC.L) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages

Arecor Therapeutics plc (AREC.L) Enterprise Value vs. Peers

How is AREC.L’s Enterprise Value compared to its peers?

Arecor Therapeutics plc’s Enterprise Value is greater than Poolbeg Pharma PLC (16.53M), greater than Novacyt S.A. (8.66M), greater than Aptamer Group plc (19.58M), greater than Sareum Holdings plc (14.40M), less than Renalytix Plc (29.89M), less than Hemogenyx Pharmaceuticals Plc (37.91M), greater than Fusion Antibodies plc (22.01M), greater than Genflow Biosciences plc (7.83M), greater than OptiBiotix Health Plc (5.67M), greater than IXICO plc (6.62M),

Build a custom stock screener for Arecor Therapeutics plc (AREC.L) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Arecor Therapeutics plc using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Arecor Therapeutics plc (AREC.L) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Arecor Therapeutics plc or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.